Alexander Korn

1.9k total citations · 1 hit paper
41 papers, 1.5k citations indexed

About

Alexander Korn is a scholar working on Transplantation, Molecular Biology and Physiology. According to data from OpenAlex, Alexander Korn has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Transplantation, 11 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Alexander Korn's work include Renal Transplantation Outcomes and Treatments (15 papers), Alzheimer's disease research and treatments (11 papers) and Protein Structure and Dynamics (7 papers). Alexander Korn is often cited by papers focused on Renal Transplantation Outcomes and Treatments (15 papers), Alzheimer's disease research and treatments (11 papers) and Protein Structure and Dynamics (7 papers). Alexander Korn collaborates with scholars based in Germany, Switzerland and United States. Alexander Korn's co-authors include Ludwig Kappos, T Haas, Giancarlo Comi, Goeril Karlsson, Paul O’Connor, Ernst W. Radue, Xavier Montalbán, Jack P. Antel, Chris H. Polman and Christine L.M. Joseph and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Physical Chemistry B.

In The Last Decade

Alexander Korn

39 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

2006 824 citations Ludwig Kappos, Jack P. Antel et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Alexander Korn

Since Specialization

Citations

This map shows the geographic impact of Alexander Korn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Korn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Korn more than expected).

Fields of papers citing papers by Alexander Korn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Korn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Korn. The network helps show where Alexander Korn may publish in the future.

Co-authorship network of co-authors of Alexander Korn

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Korn. A scholar is included among the top collaborators of Alexander Korn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Korn. Alexander Korn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Digital Miniature Factory as Foundation for Smart Connected Production Systems 2023 ·SSRN Electronic Journal ·(unknown), (unknown), (unknown), (unknown), Alexander Korn	0
2	Peptide backbone modifications of amyloid β (1–40) impact fibrillation behavior and neuronal toxicity 2021 ·Scientific Reports ·Benedikt Schwarze, Alexander Korn, Corinna Höfling, Ulrike Zeitschel, Martin Krueger, Steffen Roßner, Daniel Huster	9
3	Myofibroblasts have an impact on expression, dimerization and signaling of different ErbB receptors in OSCC cells 2016 ·Journal of Receptors and Signal Transduction ·(unknown), Alexander Berndt, Christina Valkova, Petra Richter, Alexander Korn, Christian Kosan, Claus Liebmann	3
4	Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months 2009 ·Nephrology Dialysis Transplantation ·Andreas Scherer, Wilfried Gwinner, Michael Mengel, Torsten Kirsch, Friedrich Raulf, Joseph D. Szustakowski, Nicole Hartmann, Frank Staedtler, (unknown), J Klupp, Alexander Korn, Jeanne Kehren, Hermann Haller	35
5	Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis breakdown → 2006 ·New England Journal of Medicine ·Ludwig Kappos, Jack P. Antel, Giancarlo Comi, Xavier Montalbán, Paul O’Connor, Chris H. Polman, T Haas, Alexander Korn, Goeril Karlsson, Ernst W. Radue	824
6	Safety and efficacy of an alternative basiliximab (Simulect) regimen after renal transplantation: administration of a single 40-mg dose on the first postoperative day in patients receiving triple therapy with azathioprine. 2003 ·PubMed ·(unknown), Petr Bachleda, M Lao, (unknown), P Navrátil, Vladislav Třeška, H. Prestele, (unknown), Alexander Korn	7
7	Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12 2003 ·Transplantation ·Joseph Lawen, Elizabeth Davies, Georges Mourad, F. Oppenheimer, M. González Molina, Lionel Rostaing, Alan Wilkinson, Laura L. Mulloy, B. Bourbigot, H. Prestele, Alexander Korn, (unknown)	113
8	Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies 2003 ·Transplantation ·Andreas Scherer, Andreas Krause, John R. Walker, Alexander Korn, D. Niese, Friedrich Raulf	86
9	Safety and efficacy of an alternative basiliximab (Simulect) regiment after renal transplantation: administration of a single 40-mg dose on the first postoperative day in patients receiving triple therapy with azathioprine 2003 ·Transplant International ·(unknown), Petr Bachleda, M Lao, (unknown), P Navrátil, Vladislav Třeška, H. Prestele, (unknown), Alexander Korn	6
10	Basiliximab in pediatric liver transplantation: A pharmacokinetic‐derived dosing algorithm 2002 ·Pediatric Transplantation ·John M. Kovarik, Bruno Gridelli, Steven R. Martin, Burkhard Rodeck, Michael Melter, Stephen P. Dunn, Robert M. Merion, Andreas G. Tzakis, (unknown), John C. Bucuvalas, Harvey L. Sharp, Christophe Gerbeau, Lawrence Chodoff, Alexander Korn, Michael Hall	26
11	A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations1 2002 ·Transplantation ·John M. Kovarik, G. Offner, M. Broyer, Patrick Niaudet, Chantal Loirat, Mark Mentser, Jacques M. Lemire, John F. S. Crocker, Pierre Cochat, Godfrey Clark, Christophe Gerbeau, Lawrence Chodoff, Alexander Korn, Michael Hall	42
12	Within-patient controlled assessment of the influence of basiliximab on cyclosporine in pediatric de novo renal transplant recipients 2001 ·Transplantation Proceedings ·John M. Kovarik, Alexander Korn, Lawrence Chodoff	4
13	Basiliximab can be administered safely and effectively in a single dose on day 1 postrenal transplantation in patients receiving triple therapy with azathioprine 2001 ·Transplantation Proceedings ·(unknown), Petr Bachleda, (unknown), P Navrátil, M Lao, Vladislav Třeška, H. Prestele, (unknown), Alexander Korn	8
14	MULTICENTER STUDY OF THE SAFETY AND TOLERABILITY OF BASILIXIMAB (SIMULECT®) IN DE NOVO PEDIATRIC RENAL TRANSPLANTATION. 2000 ·Transplantation ·G. Offner, M. Broyer, Chantal Loirat, Mark Mentser, Jacques M. Lemire, John F. S. Crocker, Pierre Cochat, Godfrey Clark, (unknown), Alexander Korn, Lawrence Chodoff, (unknown)	5
15	Comparison of efficacy, safety, and tolerability of neoral vs sandimmun in de novo renal transplant patients over 24 months' treatment 1997 ·Transplantation Proceedings ·D. Abendroth, B. Buchholz, W. Land, (unknown), M. Wiesel, (unknown), Alexander Korn, (unknown)	16
16	Long-term experience with sandimmun neoral: Results in de novo and stable renal transplant patients after 24-month treatment 1997 ·Transplantation Proceedings ·Alexander Korn, L. Färber, (unknown), B. Buchholz, G. Offermann	5
17	Der Einfluß von Diltiazem auf die Konzentration von Cyclosporin-Metaboliten bei mit Sandimmun® und Neoral® behandelten nierentransplantierten Patienten 1997 ·Medizinische Klinik ·H Sperschneider, (unknown), Alexander Korn, Uwe Christians	5
18	External Ventricular Drainage for Treatment of Rapidly Progressive Posthemorrhagic Hydrocephalus 1992 ·Neurosurgery ·M. Weninger, Hans Salzer, Arnold Pollak, (unknown), Peter Vorkapic, Alexander Korn, (unknown)	3
19	External Ventricular Drainage for Treatment of Rapidly Progressive Posthemorrhagic Hydrocephalus 1992 ·Neurosurgery ·M. Weninger, Hans Salzer, Arnold Pollak, (unknown), Peter Vorkapic, Alexander Korn, (unknown)	40
20	Thoracic Vertebrostenosis Combined with Thoracic Disc Herniation 1987 ·Spine ·K. Ungersböck, A. Perneczky, Alexander Korn	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact